Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Compare Drugs in Neonatal Fc Receptor Blocker [EPC]

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
Drug Reports Deaths Death Rate Hosp. Life-Threat. Avg Age % Female
ROZANOLIXIZUMAB 303 9 3.0% 114 4 61.3 yrs 60.9%
EFGARTIGIMOD ALFA 249 26 10.4% 115 23 54.0 yrs 82.5%

Head-to-Head Comparisons

ROZANOLIXIZUMAB vs EFGARTIGIMOD ALFA
← Back to Neonatal Fc Receptor Blocker [EPC] Class side effects →